VanEck Biotech
CL$153,000
17
+CL$0+0% Friday 18:49
统计数据
当日最高
168,000
当日最低
168,000
52周最高
168,000
52周最低
136,730
成交量
1
平均成交量
0
市值
-
市盈率
-
股息收益率
0.43%
股息
665.46
即将到来
股息
0.43%股息收益率
10年增长
N/A
5年增长
13.32%
3年增长
24.37%
1年增长
6.86%
人们还关注
此列表基于关注BBHCL.SN的Stock Events用户的观察列表。这不是投资建议。
竞争者
这个列表是基于最近市场事件的分析。这不是投资建议。
iShares Biotechnology
IBB
市值7.41B
SPDR Biotech
XBI
市值7.19B
First Trust NYSE Arca Biotechnology Index Fund
FBT
市值1.12B
Virtus LifeSci Biotech Products
BBP
市值20.68M
Virtus LifeSci Biotech Clinical Trials
BBC
市值10.22M
Invesco Biotechnology & Genome
PBE
市值257.31M
Principal Healthcare Innovators
BTEC
市值16.4M
ALPS Medical Breakthroughs
SBIO
市值104.11M
Global X Genomics & Biotechnology
GNOM
市值95.21M
iShares Genomics Immunology and Healthcare
IDNA
市值135.25M
关于
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Show more...
首席执行官
国家
US
ISIN
US92189F7261